Finished Formulations
A comprehensive portfolio of dosage forms including solid orals, liquids, and sterile injectables manufactured to global quality standards.
Product Overview
Finished pharmaceutical formulations represent the final dosage forms delivered to patients — and they demand the highest levels of GMP compliance, batch consistency and regulatory documentation. PEC Pharma manufactures a broad portfolio of finished formulations spanning solid oral dosages, capsules, liquid suspensions and sterile injectables, serving therapeutic areas from antidiabetics and anti-hypertensives to antibiotics, PPIs and critical care injectables.
Our formulation catalogue is structured by dosage form and therapeutic category, enabling procurement teams and regulatory affairs professionals to identify suitable products for dossier filing, tender supply or private-label partnerships. Each product is manufactured under exacting quality protocols within our multipurpose plant infrastructure.
PEC Pharma's finished formulation business complements our Complex API, intermediate, impurity and CDMO capabilities — offering partners an integrated source for both drug substance and drug product supply. With 50+ ready-to-file DMF and ACTD dossiers for APIs and formulations, we support faster product registration in international markets.
Applications
- Antidiabetic therapy — Metformin, Sitagliptin, Dapagliflozin and combination tablets
- Cardiovascular management — Telmisartan, Amlodipine, Losartan, Ramipril and combination anti-hypertensive tablets
- Antibiotic treatment — Azithromycin, Ciprofloxacin, Levofloxacin, Metronidazole and combination products
- Gastrointestinal care — Omeprazole, Pantoprazole, Rabeprazole and PPI combination capsules
- Pain and inflammation — NSAID tablets, capsules and oral suspensions
- Cough and cold — multi-ingredient syrups and suspensions for paediatric and adult use
- Critical care — adrenaline, dopamine, furosemide and other sterile injectable presentations
Benefits
- Comprehensive dosage form coverage — tablets, capsules, suspensions and injectables
- Broad therapeutic portfolio spanning chronic disease, acute care and hospital injectables
- Regulatory dossier support with 50+ ready-to-file DMF and ACTD documents
- Manufacturing at PEC Pharma's multipurpose plant with quality-controlled laboratory support
- Export experience across LATAM, CIS, SEA and Africa markets
- Combination products available for simplified patient adherence and market differentiation
Manufacturing Process
Finished formulations are manufactured in dedicated production areas within PEC Pharma's multipurpose plant. Solid oral products follow granulation, compression and coating workflows as required by individual formulations. Capsule products are filled under controlled environmental conditions, and liquid suspensions are prepared with validated mixing and homogenisation procedures.
Sterile injectable products are manufactured under aseptic or terminal sterilisation protocols appropriate to each presentation. In-process controls and finished product testing are conducted through our well-equipped quality-controlled laboratory, ensuring batch-to-batch consistency and compliance with customer specifications.
PEC Pharma collaborates with manufacturers complying with regulatory support for both domestic and international markets. Our investment in product development with DMF and dossier regulatory support enables partners to achieve faster market entry.
Industries Served
- Generic pharmaceutical companies filing country-specific formulation dossiers
- Hospital and institutional supply organisations sourcing injectable products
- Pharmaceutical distributors in LATAM, CIS, SEA and Africa
- Private-label and contract manufacturing partners
- NGO and government tender programmes requiring essential medicines
- Domestic Indian pharma companies expanding product portfolios
Technical Specifications
Product specifications are defined per individual formulation and target market pharmacopoeia. The tables below list our current finished formulation portfolio organised by dosage form and therapeutic category.
- Dosage forms: tablets, capsules, oral suspensions, sterile injectables
- Therapeutic categories: antidiabetics, anti-hypertensives, antibiotics, PPIs, NSAIDs, cough/cold, critical care
- Combination products available across multiple therapeutic classes
- Certificate of Analysis and batch documentation with commercial supply
- Stability data and dossier documentation available for filing partners
Packaging Details
Primary packaging is selected per dosage form — blister packs and bottles for solid orals, amber glass or suitable polymer containers for liquids, and ampoules or vials for injectable presentations. Secondary packaging and export labelling comply with destination market requirements.
Custom pack sizes, multilingual labelling and tender-specific packaging configurations can be discussed during the commercial enquiry process.
Tablets
| Category | Composition |
|---|---|
| Antidiabetics |
|
| Anti-Hypertensive |
|
| Antibiotics |
|
Capsules
| Category | Composition |
|---|---|
| PPIs |
|
| Neuropathic Pain |
|
| Antimuscarinic |
|
| Antifungal |
|
| Antibiotic |
|
| NSAIDs |
|
Suspensions
| Category | Composition |
|---|---|
| Cough & Cold |
|
| NSAIDs/Analgesic & Antiemetics |
|
| Antihistaminic/Anti-Allergic |
|
| Urinary Alkalinizer |
|
| Anti-Helmintic |
|
| Antacid/Laxatives |
|
Injectables
| Sr. No | Product Name |
|---|---|
| 1 | Adrenaline Injection 1mg/ml (EPINEPHRINE) |
| 2 | Ambroxol Hydrochloride Injection 7.5 mg/ml |
| 3 | Analgin Injection 500 mg/ ml (Metamizole/Dipyrone) |
| 4 | Artemether Injection 40mg/ml, 80mg/ml |
| 5 | Atropine sulphate injection 0.6mg/ml, 1mg/ml |
| 6 | Bupivacaine Hydrochloride 5mg + dextrose 80mg Injection |
| 7 | Buprenorphine Hydrochloride Injection 0.3mg/ml |
| 8 | Caffeine Citrate Injection 20 mg/ml |
| 9 | Cholecalciferol (Vit D3) Injection 3LacIU (7.5mg)/ml, 6LacIU (15mg)/ml |
| 10 | Citicoline Sodium injection 125 mg/ml |
| 11 | Citicoline Sodium injection 250 mg/ml |
| 12 | Clindamycin Injection 150 mg/ml |
| 13 | Combipack: Diclofenac Sodium + Orphenadrine Injection |
| 14 | Dexmedetomidine Hydrochloride Injection 100mcg/ml |
| 15 | Diazepam Injection 5mg/ml |
| 16 | Diclofenac sodium Injection 25mg/ml |
| 17 | Dobutamine Hydrochloride Injection 50mg/ml |
| 18 | Dopamine Hydrochloride Injection 40mg/ml |
| 19 | Ephedrine Sulfate Injection 25mg/ml |
| 20 | Etophylline 84.7 mg/ml + Theophylline 25.3 mg/ml Injection |
| 21 | Fentanyl Citrate Injection 50mcg/ml |
| 22 | Fluphenazine Decanoate Injection 25 mg/ml |
| 23 | Furosemide Injection 10mg/ml |
Frequently Asked Questions
What dosage forms does PEC Pharma manufacture?
We manufacture tablets, capsules, oral suspensions and sterile injectables across a wide range of therapeutic categories including antidiabetics, anti-hypertensives, antibiotics, PPIs and critical care products.
Are combination products available?
Yes. Our portfolio includes multiple fixed-dose combination tablets and capsules — for example Metformin + Glimipride, Telmisartan + Amlodipine, and PPI + Domperidone combinations. See the product tables for the full list.
Does PEC Pharma provide dossier documentation for formulation filing?
PEC Pharma has 50+ ready-to-file DMF and ACTD dossiers for APIs and formulations. Contact our team to discuss dossier availability for specific products and target markets.
Which injectable products are in your portfolio?
Our injectable range includes products such as Adrenaline, Artemether, Atropine sulphate, Dopamine, Furosemide, Diclofenac sodium and many more. See the injectables table for the complete list.
How do I request a formulation supply quote?
Submit an enquiry via our contact form with the product name, dosage form, required quantity and destination market. Our commercial team will confirm availability, pricing and regulatory documentation support.